NIH-funded research R01 grant

Allelic Dio3 control of brain development and behavior in mood and neurodevelopmental disorders

Official title: Allelic Dio3 control of brain development and behavior

Funded at Mainehealth · NIH-11305356 · Data updated 2026-11-12

A research project explores how a gene called Dio3 might shape brain development and behavior, potentially helping people with mood and neurodevelopmental conditions.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMainehealth
NIH-funded
Lab location1 site (Portland, United States)
Project startJune 24, 2026
Project endMarch 31, 2031
Funding year2026
Award (this year)$466,738
NIH project number1R01MH139529-01A1
Project IDNIH-11305356 on NIH RePORTER

Who could benefit from this research

Could help

Individuals with affective or neurodevelopmental conditions, including ADHD, ASD, or mood disorders, and appropriate adult or adolescent participants as determined by the study.

Less likely to help

People without neurodevelopmental or affective disorders are unlikely to directly benefit from this grant.

What this research studies

This project looks at how variations in the Dio3 gene and thyroid hormone signaling during brain development might contribute to conditions like autism, ADHD, and mood disorders. Researchers will examine genetic expression, epigenetic factors, and sex differences to understand why these disorders emerge and affect males and females differently. The study uses human-relevant approaches and may involve analysis of brain development processes and related data to uncover potential targets for prevention and treatment. By studying how environmental influences could alter gene activity, the work aims to reveal new insights into the origins of neurodevelopmental and affective disorders.

Why it matters

Potential benefit: If successful, the research could identify new genetic or developmental pathways that lead to mood and neurodevelopmental disorders, guiding earlier diagnosis and new therapeutic strategies.

How similar studies have gone: Previous work shows that genetic and epigenetic factors influence brain development and psychiatric risk, but the Dio3-specific pathway remains to be clarified.

Where this research is happening

  • Mainehealth
    Portland, United States
    Active

Researchers

  • Principal investigator: Hernandez, Arturo — Mainehealth
  • Study coordinator: Hernandez, Arturo

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.